(1)
Gupta, V. K.; Pannu, D.; Singh, M. P.; Kumar, L. Effect of SGLT-2 Inhibitor (remogliflozin) Plus DPP4 Inhibitor (vildagliptin) on Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus Comparison With Combination of Metformin and Sulphonylureas. Int J Adv Med 2023, 10, 446-451.